Thermo Fisher (TMO) Completes Phadia Acquisition; Boosts FY11 EPS, Revs Outlook
Tweet
Share
E-mailGet Alerts TMO Hot Sheet
Price: $544.78 +0.60%
EPS Growth %: -6.2%
Financial Fact:
Product revenues: 3.87B
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -6.2%
Financial Fact:
Product revenues: 3.87B
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Thermo Fisher Scientific Inc. (NYSE: TMO), has completed the acquisition of Phadia.
Phadia is expected to contribute $0.07 to Thermo Fisher’s 2011 full year adjusted earnings per share (EPS). This is a $0.01 increase over the original estimate of $0.06, reflecting more favorable financing rates that will primarily benefit fourth quarter results.
Thermo Fisher is increasing its fiscal 2011 EPS outlook to a range of $4.15 to $4.25 and revs to $11.79 to $11.89 billion. The Street currently sees EPS of $4.15 and revs of $11.66 billion.
Phadia is expected to contribute $0.07 to Thermo Fisher’s 2011 full year adjusted earnings per share (EPS). This is a $0.01 increase over the original estimate of $0.06, reflecting more favorable financing rates that will primarily benefit fourth quarter results.
Thermo Fisher is increasing its fiscal 2011 EPS outlook to a range of $4.15 to $4.25 and revs to $11.79 to $11.89 billion. The Street currently sees EPS of $4.15 and revs of $11.66 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Super Micro Computer (SMCI) Falls 6%
- Netflix (NFLX) raised to Buy at Needham & Company on revenue upside
Create E-mail Alert Related Categories
Corporate News, Guidance, Mergers and AcquisitionsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
